SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001193125-15-285788
Filing Date
2015-08-11
Accepted
2015-08-11 08:00:52
Documents
1
Period of Report
2015-06-30
Effectiveness Date
2015-08-11

Document Format Files

Seq Description Document Type Size
1 NT 10-Q d943604dnt10q.htm NT 10-Q 22147
  Complete submission text file 0001193125-15-285788.txt   23310
Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Filer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-Q | Act: 34 | File No.: 001-34921 | Film No.: 151042494
SIC: 2834 Pharmaceutical Preparations